Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP) and Tac1 gene-encoded tachykinins (substance P: SP, neurokinin A: NKA) are expressed in capsaicin-sensitive nerves, but their role in nociception, inflammation and vasoregulation is unclear. Therefore, we investigated the function of these neuropeptides and the NK 1 tachykinin receptor (from Tacr1 gene) in the partial sciatic nerve ligationinduced traumatic mononeuropathy model using gene deficient (PACAP −/− , Tac1 −/− , and Tacr1 −/− ) mice. Mechanonociceptive threshold of the paw was measured with dynamic plantar aesthesiometry, motor coordination with Rota-Rod and cutaneous microcirculation with laser Doppler imaging. Neurogenic vasodilation was evoked by mustard oil stimulating sensory nerves. In wildtype mice 30-40% mechanical hyperalgesia developed one week after nerve ligation, which was not altered in Tac1
Introduction
Painful neuropathy is a very important clinical problem, particularly with the growth of an elderly population, the number of people affected by these conditions is increasing. Its therapy is an emerging issue, because even with the latest developments on the field of analgesic-research, it is still not satisfactory.
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and tachykinins, such as substance P released from the capsaicinsensitive peptidergic sensory nerves were shown to be involved in acute and chronic pain conditions [2, 6, 8, 42, 45, 48, 52] , but their role in chronic neuropathic pain syndromes has not yet been clearly elucidated.
PACAP belongs to the vasoactive intestinal polypeptide (VIP)/secretin/glucagon family [31] . It is present in 27 and 38 aminoacid-containing forms, the latter is more predominant in mammals. So far three receptors of this peptide have been cloned, all of which belong to the family of G-protein coupled receptors mediating their effect through the activation of adenylate cyclase and phospholipase C. PACAP is the main endogenous agonist on the PAC1 receptor, whereas PACAP and VIP have similar affinities for the VPAC1 and VPAC2 receptors [22] . The PAC1 receptor is expressed mainly on neural and smooth muscle cells, while the VPAC1/VPAC2 are localized principally on the dorsal root ganglia (DRG), sensory nerve endings, and inflammatory cells [6, 9, 50, 55, 64] . The fact, that PACAP shows increased expression in the superficial layer of the spinal dorsal horn and in capsaicin-sensitive primary sensory neurons, suggested that it has a role in nociception [33, 34, 39, [61] [62] [63] . However, the results obtained from the early in vivo studies proved to be contradictory [41] . Intrathecally administered PACAP-38 showed analgesic effect in the early phase, subsequently followed by a long-lasting algesia in the formalin test [48] . In several other models centrally applied PACAP showed marked pro-nociceptive effects: it decreased thermal stimulation-evoked paw withdrawal latencies and potentiated nociceptive transmission to the dorsal horn [37] . It facilitated spinal nociceptive flexor reflexes [41, 60] and induced hyperalgesia [35] . We provided evidence that PACAP-38 exerts an interesting divergent effect on pain-signaling. Peripherally administrated PACAP induces anti-nociceptive, anti-hyperalgesic and anti-allodynic effects in both acute somatic and visceral pain models. However, it does not affect mechanical hyperalgesia in the traumatic mononeuropathy model, but induces sensitization of knee joint primary afferents [42] . Furthermore, PACAP inhibits the release of several pro-nociceptive and pro-inflammatory sensory neuropeptides (CGRP, SP and other tachykinins) from peripheral terminals of capsaicin-sensitive nerves, and it diminishes acute neurogenic and non-neurogenic inflammatory processes [10, 17, 36] . We also described, that PACAP has a dual role in nociception. Thermal allodynia mediated only by peripheral mechanisms is increased in PACAP gene-deficient animals, but somatic and visceral nocifensive behaviors, and neuropathic mechanical hyperalgesia are diminished. This demonstrates that PACAP can have both inhibitory and excitatory roles depending on the site of action and the predominant mechanism in the pain model [44] .
Tachykinins represent one of the largest families of neuropeptides released from the capsaicin-sensitive sensory nerve terminals. All of these peptides are relatively small, their average length is 10-11 aminoacids. So far three tachykinin encoding genes have been cloned (Tac1, Tac3, and Tac4), but the number of the tachykinins is much larger due to post-translational modifications [26, 38] . The first identified preprotachykinin-A (PPTA; Tac1) gene encodes substance P (SP) and Neurokinin-A (NKA). This gene is expressed predominantly in sensory neurons, inflammatory and immune cells [40] . SP and NKA exert a variety of effects under both normal and pathophysiological conditions. They induce neurogenic inflammation (vasodilation, plasma protein extravasation, and stimulation of inflammatory cells), elicit smooth muscle contraction, regulate vascular tone, mucus secretion and immune functions [26] . They induce the release of histamine and serotonin through mast cell activation, which in turn increases the neuropeptide-release from the sensory nerve terminals through positive feedback mechanisms [18, 51] .
Three tachykinin receptors have been cloned, the Neurokinin 1, 2, and 3 (NK 1 ; NK 2 ; NK 3 , respectively), which are Gs/Gq-protein coupled [26] . While all tachykinins can activate all receptors, SP and NKA are the preferred ligands for the NK 1 and NK 2 receptors [15, 23, 27] . The involvement of the Tac1 gene-encoded tachykinins in several models of chronic inflammation and pain has been suggested [13] . SP and NKA are synthesized in the dorsal root ganglia, and they are involved in the regulation of nociceptive information at the first sensory synapse in the spinal cord [7, 56] . SP, NKA, and the NK 1 receptor have been suggested to be involved in inflammatory and neuropathic pain syndromes, such as traumatic mononeuropathies [2, 11, 12] , streptozotocin-induced diabetes [5] , and paclitaxel-induced peripheral neuropathy [52] . However, in these studies only the alterations of NK 1 receptor expression was investigated or the effect of non-peptide NK 1 receptor antagonists were analyzed, as Tac1 and NK 1 gene deficient animals were until recently not available.
Since PACAP and tachykinins are co-localized in capsaicinsensitive afferents, our aim was to elucidate their roles in a model of traumatic mononeuropathy with the help of gene-deleted mice. Furthermore, the involvement of the NK 1 receptor, the main target of SP, was also investigated. In order to have an integrative approach, different functional techniques to assess neuropathic mechanical hyperalgesia, motor coordination, and neurogenic vasodilation were used.
Materials and methods

Animals
Experiments were performed with PACAP, Tac1 and Tacr1 gene-deficient (PACAP −/− , Tac1 −/− and Tacr1 −/− ) mice and their respective, appropriate wildtype counterparts. The generation of PACAP −/− mice on the CD1 background at the Osaka University has been previously described in details [14] . The heterozygous mice (PACAP +/− ) were backcrossed for 10 generations with the CD1 strain. After genotyping the offsprings of the first generation of the PACAP +/− breeding pairs, mice were bred on as wildtype (PACAP +/+ ) and homozygous gene-deleted (PACAP −/− ) lines in the Laboratory Animal House of the Department of Pharmacology and Pharmacotherapy of the University of Pécs. Offsprings within the first three generations were used for the experiments to minimize genetic variations. The SP and NKA deficient (Tac1 −/− ) and NK 1 receptor gene-deleted (Tacr1 −/− ) mice were generated on the C57Bl/6 background at the University of Liverpool and the University of Bonn, respectively, as previously described [16] . The homozygous gene-deleted animals were backcrossed for8-10 generations to the C57Bl/6 strain, therefore, these mice were used as wildtype (WT) controls. Their original breeding pairs were purchased from Charles-River Ltd. 
The traumatic mononeuropathy model
Anesthesia was performed with a combination of 100 mg/kg ketamine i.p. (Richter Gedeon Plc., Budapest, Hungary) and 5 mg/kg xylazine i.m. (Lavet Ltd., Budapest, Hungary). Then the right common sciatic nerve was unilaterally exposed high in the thigh and its 1/3 was tightly ligated using an atraumatic siliconized silk suture (Ethicone 10-0) [28, 47] . Thereafter the wound was closed, and the animals were not examined for the next 7 days in order not to disturb the healing process. In accordance with our previous studies [42, 44] , this is a reliable model of neuropathic mechanical hyperalgesia, which is not influenced by an impaired weight distribution.
Determination of the mechanonociceptive threshold by dynamic plantar aesthesiometry
The mechanonociceptive threshold of plantar surface of the hindpaw was measured by dynamic plantar aesthesiometry (Ugo Basile 37400, Comerio, Italy). In this device the animals can freely move in their separate compartments on a metal mesh. Prior to each measurement there was 10-15 min of acclimation period until the cessation of the animals exploratory behavior. Then the stimulator unit of the device was placed under the animal's paw, using an adjustable angled-mirror to aid the positioning of the metal filament right below the plantar surface. Then an electrodynamic actuator of proprietary design lifted the straight metal filament, which touched the plantar surface and began exerting an increasing upward force at a preset rate (5 s) of application until either the nocifensive behavior (removal of the paw) was attained, or until the maximal 10 g was reached. After a conditioning and 3 control preoperative measurements, the paw withdrawal thresholds were determined on days 7, 10, 14, 19 after the nerve ligation.
Assessment of the motor coordination on a Rota-Rod
Motor functions were studied using an accelerating Rota-Rod device (Ugo Basile 7750, Comerio, Italy). This instrument consists of a constantly faster rotating drum, which is divided into four separate compartments, each for a single animal. Before the beginning of the experiment, we performed 3 training measurements on three consecutive days. The motor performance was indicated by the duration of time (s) spent on the rotating drum [43] . Every measurement was repeated 5 times for each animal, and their means were used for evaluation.
Measurement of cutaneous microcirculation by laser Doppler scanning
Microcirculation in the plantar skin of the hindpaw was measured by laser doppler imaging (Perimed PIM II, Stockholm, Sweden). The mechanism of this device is based on the Dopplerprinciple, as it emits a monochromatic (wave length: 670 nm) laser beam, which is reflected from the moving red blood cells. As the reflected laser beam passes through Doppler-shift, detecting its wave-length allows us to measure the rate of blood flow in the superficial capillaries. Because most of the laser light is absorbed in the superficial tissues, the blood flow of the larger blood vessels does not disturb the measurement. Mice were anesthetized with urethane (2.4 g/kg i.p.), their body temperature was maintained at 37 • C with a controlled heating pad. At the beginning of the experiment 3-4 control images of the plantar surfaces of both the operated and the intact contralateral hindpaws were taken simultaneously to obtain stable baseline flow data. Then 30-30 l of 5% mustard-oil (allyl-isothiocyanate) was applied topically on both plantar surfaces to induce neurogenic vasodilatation. This chemical compound is a Transient Receptor Potential Ankyrin 1 (TRPA1) receptor agonist, therefore, it induces the release of vasoactive neuropeptides from the intact sensory nerve endings, which in turn leads to an increased blood flow in the innervated area (neurogenic vasodilation). The plantar microcirculation was measured for 60 min after mustard oil application. Altogether an average of 30 images were recorded for each animal including the initial control measurements. 5% mustard-oil was prepared freshly before the beginning of the experiment from the same concentrated solution. All knockout and wildtype mice were measured within a time limit of 48 h to decrease the possible environmental interferences.
Statistical analysis
All data were expressed as means with standard errors of means (s.e.m.). For statistical evaluation repeated measures ANOVA followed by Bonferroni's modified t-test was used for the assessment of mechanical hyperalgesia and motor performance, whereas the results of the laser doppler imaging were evaluated using twoway ANOVA and Bonferroni's modified t-test. When comparing the results *p < 0.05 was considered statistically significant.
Results
Mechanical hyperalgesia in response to partial ligation of the sciatic nerve
The initial control mechanonociceptive thresholds of PACAP −/− mice were similar to the wildtypes. Tight ligation of 1/3 of the sciatic nerve induced a significant, about 30-40% decrease of the threshold of the affected hindpaw in wildtype animals between the 7th and 19th postoperative days. In comparison, neuropathic mechanical hyperalgesia was minimal in the PACAP −/− group, the nociceptive threshold remained similar to the initial control values throughout the total duration of the experiment (Fig. 1A) .
The preoperative mechanonociceptive thresholds of C57Bl/6 wildtype mice did not differ significantly from either the PACAP +/+ wildtypes generated on the CD1 background or the Tac1 −/− and the Tacr1 −/− ones. Furthermore, the 35-45% mechanical hyperalgesia detected in response to the nerve ligation was also very similar in all the three groups, SP/NKA or NK 1 receptor deficiency did not influence its development during the whole study (Fig. 1B and C) .
Changes of the motor functions
The basal motor performance on the accelerating Rota-Rod was significantly worse in both the PACAP −/− and Tac1 −/− groups compared to the respective wildtypes ( Fig. 2A and B) . In contrast, deletion of the NK 1 tachykinin receptor (Tacr1 −/− ) did not influence the motor coordination (Fig. 2C) . The partial sciatic nerve ligation did not influence the motor coordination in any of the groups. During the control pre-operative and even the post-operative periods a continuous learning process was observed in the wildtype and the PACAP and Tac1 gene-deleted groups, but not in Tacr1 −/− animals. However, the basal impaired motor coordination in PACAP −/− and Tac1 −/− mice was also observed after the operation ( Fig. 2A and B) .
Changes of cutaneous blood flow and neurogenic vasodilation
In both wildtype (PACAP +/+ and C57Bl/6) and all the three gene-deficient (PACAP −/− , Tac1 −/− , Tacr1 −/− ) groups, the basal microcirculation in the plantar skin was reduced on the operated limb, but the difference was not statistically significant. The basal perfusion was significantly higher in the black C57Bl/6, Tac1 −/− , but not Tacr1 −/− mice as compared to the white PACAP +/+ and PACAP −/− ones generated on the CD1 background. Meanwhile, topical application of 5% mustard oil activating the capsaicin-sensitive sensory nerve terminals in the skin and inducing neuropeptide release evoked significantly smaller neurogenic vasodilator response in the C57Bl/6-based groups compared to the CD1-based ones (15-20% vs. 50-60%). This clearly indicates a remarkable strain difference in the regulation of microcirculation (Figs. 3-5) .
Basal perfusion in the plantar skin of both the operated and intact limbs of PACAP +/+ and PACAP −/− mice did not differ significantly (3.4 ± 0.32 V, vs. 3.97 ± 1.04 V). In response to activation of the capsaicin-sensitive sensory nerve terminals by topical application of 5% mustard oil microcirculation similarly increased by 50-60% in both groups on both sides after 5-10 min. This neurogenic vasodilation response persisted in wildtype mice during the next 60 min of the experiment, whereas in PACAP −/− animals it started to decrease after 10-15 min Significantly lower perfusion was detected in the PACAP −/− group from the 30th minute of the measurement (Figs. 3 and 4A and B) .
In the Tac1 −/− and Tacr1 −/− groups the basal cutaneous microcirculation was significantly lower on both limbs compared to the C57Bl/6 wild types (Fig. 5) . In response to mustard oil smearing the perfusion increased steadily by 15-20% on both limbs of the wildtype mice. In contrast, in cases of SP/NKA and NK1 receptor deficiency there was an initial transient decrease on the intact side, but after the first 10 min, the blood perfusion did not differ significantly from the results of the C57Bl/6 wildtype animals for the rest of the experiment (Fig. 5 ).
Discussion
These results provide clear evidence that: (1) Under normal conditions PACAP and tachykinins play important roles in motor coordination, but they are not involved in mechanonociception. (2) Tachykinins regulate the basal cutaneous microcirculation through NK 1 receptor activation, but PACAP is involved in neurogenic vasodilation. (3) Partial ligation of the sciatic nerve, which is a widely used traumatic mononeuropathy model, induces purely sensory neuropathy (mechanical hyperalgesia) without affecting the motor and the vascular functions. (4) PACAP is a crucial mediator of neuropathic hyperalgesia.
Our earlier data showing that PACAP has a hyperalgesic and pro-nociceptive role in a variety of pain models are in agreement with the present findings [42] . Others also showed that PACAP might play a key role in spinal sensitization, and therefore, in the development of neuropathic pain [8, 25] through PAC1 receptor activation in the dorsal root ganglia [6, 20] . Furthermore, PACAP is likely to have a pivotal pro-nociceptive function in animal models of migraine and also in human migraneurs [29, 46, 54] . Others suggested that the peripheral nociceptive responses elicited by intradermally administered PACAP are mainly mediated through the VPAC receptors [45] . Therefore, identification of the targets and the mechanisms of the hyperalgesic actions of PACAP still need further investigations.
While the increased expression of the Tac1 gene-encoded tachykinins in the dorsal root ganglia under neuropathic conditions has been established [57] , our results indicate that SP/NKA and the NK 1 receptor do not play an important role in the development of neuropathic hyperalgesia. Studying the analgesic mechanisms of the action of topical capsaicin application in neuropathies, it was found that the increased expression of SP has only marginal effect, and capsaicin exerts its therapeutic benefit through other pathways [1] . Other results also indicate that SP/NKA up-regulation is not a crucial factor in the development of neuropathies: while it was found to be involved in the development of paclitaxel-induced neuropathy, oxaliplatin treatment leads to a similar condition without influencing the SP/NKA release [52] .
The motor coordination of the PACAP and Tac1 gene deficient animals was significantly worse than their wildtype counterparts under both normal and neuropathic conditions, while the motor performance of the NK 1 receptor deficient group was similar to the control animals. These results suggest, that PACAP and SP/NKA might have a potential role as mediators of normal motor coordination. However, this effect of the tachykinins is not mediated through the NK 1 receptor, but the action of NKA at the NK 2 tachykinin receptor can be suggested. These findings are supported by earlier data showing that PACAP may contribute to the regulation of motor coordination, though the mechanism and the site of action has not been described [30] . Currently there is less data available about the potential role of the Tac1 gene encoded tachykinins, but the few earlier results obtained in markedly different models (less complex species) also indicate that tachykinins might also affect the motor coordination [21] . SP has been suggested to have a protective role in an animal model of amyotrophic lateral sclerosis, which is due to motor neuron degeneration, supporting its role in motor coordination [3] . SP and the NK 1 receptor activation may also have a potential role in the development of Parkinson's disease, in which the loss of motor coordination is the principal symptom. Increased SP expression in this model accelerated disease progression, whereas NK 1 receptor antagonist treatment improved the motor performance [53] . The significant mechanical hyperalgesia, but normal motor performance and cutaneous microcirculation observed in response to the sciatic nerve ligation indicates, that although it contains sensory, motor and autonomic fibers, the traumatic mononeuropathy induced by this operative process is exclusively of sensory nature and it does not hinder either the motor performance or the vascular regulation. Besides neuropathic hyperalgesia, PACAP is involved in the development of neurogenic vasodilation, particularly in its long-term maintenance. As mustard oil activating the capsaicinsensitive afferents predominantly via TRPA1 ion channel activation induced a remarkable initial vasodilation in PACAP deficient mice, which very rapidly decreased, it is suggested, that PACAP contributes to the later, stable phase of neurogenic vasodilation. Other sensory neuropeptides released from the stimulated sensory nerves, such as CGRP are likely to be responsible for the early phase of this response.
As the basal blood flow was significantly lower in both Tac1 and Tacr1 gene-deficient mice, SP through NK 1 receptor activation is likely to play an important role in the mediation of the basal vascular tone, it dilates the cutaneous vessels. However, they do not have an important function in neurogenic vasodilation. It should be noted that the well established effect of SP in neurogenic inflammation is increasing venular permeability, a phenomen which was not measured with the laser Doppler scanning [19] . In addition, CGRP is considered as the most potent mediator of vasodilation [24] . It was suggested, that the NK 1 receptor activation serves to increase indirectly the production of nitric oxide (NO) and other local vasodilatory substances, however it is accepted, that there is a lot of interactions between the neuropeptides, local mediators, and receptors involved in this process, and the responsible pathways are redundant [59] . It must be taken into account, that SP is not the sole endogenous ligand of the NK 1 receptor, on which the other known tachykinins also act as potent agonists, therefore probably bypassing the role of the lacking SP/NKA. In addition it is established, that though tachykinins are in most conditions potent vasodilators, in different models or species they can induce vasoconstriction, and that their net effect is heavily influenced by the local differences of the endothelium [58] . This assumption also correlates with the fact, that so far no substance could be labeled as the exclusive mediator of cutaneous vasodilation [4, 24] .
We found remarkable strain differences between the C57Bl/6 and CD1 mice (PACAP +/+ ) in the examined sensory, motor and vascular parameters. It is not surprising, since a large number of papers described such findings, and reviews focus on the issue of strain difference [32, 49] . Describing these differences is in fact valuable, and highlights the importance of using the appropriate wildtypes when interpreting data of gene-deficient mice. In the present experimental series we did not aim to compare the tachykinin and NK 1 deficient mice with the PACAP knockouts, but only to compare them with their respective and appropriate wildtypes in order to elucidate their role in the investigated biological functions. The conclusions were drawn from the results separately.
It can be concluded that (1) PACAP has an overall pronociceptive role in peripheral traumatic neuropathy. (2) PACAP and SP/NKA are both involved in motor coordination, while the lack of the NK 1 receptor does not affect this function. (3) Tac1 gene products and NK 1 receptor have a pivotal role in the maintenance of basal vascular tone, whereas PACAP is a key mediator of neurogenic vasodilation, particularly involved in its long-term maintenance.
